- May 16, 2017
- 3,754
- Tinnitus Since
- 04/2011
- Cause of Tinnitus
- Syringing + Somatic tinnitus from dental work
Zack's just published "Find Strong Stocks with this New Analyst Screen". Frequency Therapeutics is mentioned. Reason they gave for run-up in last 30 days is because of increase of analysts from 2 to 3. I do agree with this as being one reason and will place this as reason 2.This latest run up is bananas. It's not clear at all what's driving it. Otonomy (OTIC) has also been climbing, but not as fast and they have trial data due this month.
The top reason is demographics, meaning many investors have association to sites like here and then past thoughts on to relatives and friends by word of mouth. I would say that at least 25% of volume is from this. Also many of the investment funds that are invested in FREQ are well known to invest in small volume companies where private investors have a special interest.
At the close of market today, the Ameritrade research team advised to reduce positions. I had posted to buy at 21, a month or so ago, but there may be some profit taking until we get closer to new data readouts.